PA Consulting

(optional)

Showing 271-280 of 281 results

Sort by:

Brexit: the eye of the storm

The UK life sciences sector will undoubtedly be affected by the Brexit after the decision that Article 50 will be triggered by the end of March 2017; and it needs to start preparing now for the uncertainties ahead.

Sphere Medical

Helping diagnose and monitor patients in critical care

Building a better self-injection solution

Pharmaceutical Technology

The ingestible and stick-on micro tech powering your healthcare

Wearable tech regulated as medical devices can revolutionise healthcare

Medical Device and Diagnostic Industry

Pharmaxis

The Orbital® inhaler, developed by PA, is being used in key research to combat tuberculosis

Pharma and big data – the commercial opportunity

Big data can unlock the potential of existing medicines. By analysing data about their existing treatments, pharma companies have a real opportunity to prevent health problems that may be associated with the drugs.

10 simple rules for creating an effective portfolio of regulated documents

Rise to the biofilm challenge: harmful microbes present opportunities for innovators

What does open innovation mean to pharmaceutical R & D and how can it be realised?

Current page:

of 29

Current page: 28 of 29